FPH - Fisher Paykel Healthcare.

[Joshuatree]

A buy from The Bull.
"Reporting in May, Fisher & Paykel’s competitive advantage lies in the respiratory and acute care market where it enjoys a dominant market share. Its obstructive sleep apnoea device business has strong growth prospects, but FPH is a smaller player in this highly competitive market dominated by the likes of ResMed. Recurring revenue from high margin consumables accounts for 84 per cent of group revenue, which is a highly attractive aspect of this business."

[BlackPeter]

... and here we go: Golden Cross time! Given that markets see Trump more and more as a dog who barks a lot but has no teeth to bite (obviously - I am talking here about his ability to get anything trade or tax related through the house, not about his nuclear stick - but this is another thread) ... might it be a good time to reinvest.

I bought some parcel when FPH came back across the MA100 - and so far it looks like the indicators stay friendly

[Zaphod]

Trump has now slapped a 20% tariff on Canadian lumber, accusing the Canadian government of providing tax-payer subsidies to lumber producers, which make the prices it sells for "unfair to the USA."

Dairy appears to be next on the hit list.

I wonder how long it will be until he decides upon tariffs on Mexican produced goods. This issue could be exacerbated by the $163M WTO ruling in favour of Mexico on their dispute with exports of Tuna into the USA.

[babymonster]

back to 10, yeah... is it something to do with Resmed's result? hope it can stay...

[Joshuatree]

... and here we go: Golden Cross time! Given that markets see Trump more and more as a dog who barks a lot but has no teeth to bite (obviously - I am talking here about his ability to get anything trade or tax related through the house, not about his nuclear stick - but this is another thread) ... might it be a good time to reinvest.

I bought some parcel when FPH came back across the MA100 - and so far it looks like the indicators stay friendly

Canny indeed. S/P now $10.51 on increasing vol (getting toppy?), not far from an all time high($10.79) Why?
Not sure
Fall in $NZ ,Average of 1% higher than F&P assumed
Larger Flu season in USA
Improving political funding environs in USA (but still risks)
Rolling out new masks and flow generators etc
USA final litigation determination in USA jan 2018
Worst case scenario a ban on 2 masks which make up 10-15% rev in USA

4Traders av t/p $10.31
A broker where i got some of this info T/P $10.18 with meaningful tail risks remain

[hardt]

Canny indeed. S/P now $10.51 on increasing vol (getting toppy?), not far from an all time high($10.79) Why?
Not sure
Fall in $NZ ,Average of 1% higher than F&P assumed
Larger Flu season in USA
Improving political funding environs in USA (but still risks)
Rolling out new masks and flow generators etc
USA final litigation determination in USA jan 2018
Worst case scenario a ban on 2 masks which make up 10-15% rev in USA

4Traders av t/p $10.31
A broker where i got some of this info T/P $10.18 with meaningful tail risks remain

Resmed saw great amounts of growth in the market they share with FPH - many are expecting organic growth to bolster some good results for FPH as it did for RMD [ Resmed market share remained the same ]

With the FY results in sight, I would say there are some mighty high expectations.

[Joshuatree]

Yes RMD PE 29( i hold too) very similar chart and near a high. Prob tracking the S&P Healthcare 500 index like FPH PE 37 (ASB site) (PE 34 brokers est ).

[Joshuatree]

Was that you BP selling out today?.

[BlackPeter]

What do you mean - hardly any depth so far?

But no, don't see any reason to sell FPH at the moment. Do you?

[Joshuatree]

Well its getting fairly pricey don't you think?Im mean more than norm.
Meanwhile a new mask released for babies down to 500 gm in weight!
FPH Releases New Infant Cannula